Synopsis The global market for Exoskeleton Robot was estimated to be worth US$ 417 million in 2024 and is forecast to a readjusted size of US$ 1506 million by 2031 with a CAGR of 19.7% during the forecast period 2025-2031. Exoskeleton robots ar.....
SynopsisThe global market for Antimicrobial Silver Wound Dressing was estimated to be worth US$ 859 million in 2024 and is forecast to a readjusted size of US$ 1089 million by 2031 with a CAGR of 3.5% during the forecast period 2025-2031. This report provides a .....
SynopsisThe global market for Bilateral Cochlear Implants was estimated to be worth US$ 1606 million in 2024 and is forecast to a readjusted size of US$ 2370 million by 2031 with a CAGR of 5.8% during the forecast period 2025-2031. A cochlear implant is a small,.....
SynopsisThe global market for Medical Rubber Stoppers was estimated to be worth US$ 1183 million in 2024 and is forecast to a readjusted size of US$ 1619 million by 2031 with a CAGR of 4.7% during the forecast period 2025-2031. This report provides a comprehensi.....
SynopsisThe global market for Pet Pharmaceuticals was estimated to be worth US$ 17510 million in 2024 and is forecast to a readjusted size of US$ 28170 million by 2031 with a CAGR of 7.0% during the forecast period 2025-2031. Pet pharmaceutical refers specifical.....
SynopsisThe global market for Used and Refurbished Medical Equipment was estimated to be worth US$ 9943 million in 2024 and is forecast to a readjusted size of US$ 17350 million by 2031 with a CAGR of 8.4% during the forecast period 2025-2031. Refurbished Medica.....
SynopsisThe global market for Biopharmaceutical and Bio-CDMO was estimated to be worth US$ 28160 million in 2024 and is forecast to a readjusted size of US$ 66050 million by 2031 with a CAGR of 13.1% during the forecast period 2025-2031. Biopharmaceutical Contra.....
SynopsisThe global market for Alinia (nitazoxanide) was estimated to be worth US$ 191 million in 2024 and is forecast to a readjusted size of US$ 240 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031. Nitazoxanide, sold under the brand nam.....
SynopsisThe global market for Liposomal Doxorubicin was estimated to be worth US$ 974 million in 2024 and is forecast to a readjusted size of US$ 724 million by 2031 with a CAGR of -3.5% during the forecast period 2025-2031. This report provides a comprehensive .....
SynopsisThe global market for Intraoral Scanner was estimated to be worth US$ 1219 million in 2024 and is forecast to a readjusted size of US$ 2281 million by 2031 with a CAGR of 9.6% during the forecast period 2025-2031. Intra Oral Scanners are one of the most .....
